Role of ChatGPT in Vestibular Schwannoma Management

Vestibular Schwannoma Clinical Trial

Official title:

Role of ChatGPT in Vestibular Schwannoma Management

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06163664
• Other study ID #: UP-23-00541
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 15, 2024
• Est. completion date: November 30, 2025

Study information

• Verified date: June 2024
• Source: University of Southern California
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Previous studies have demonstrated that patients frequently undergo significant decision conflict regarding major medical decisions in otolaryngology. There lack validated tools available for decision support for patients. While limited evidence has demonstrated that clinical decision support tools can alleviate decision conflict for patients with diagnosis in otolaryngology, conversational language models were not employed in these studies and may provide additional benefit in this context. This study seeks to evaluate the efficacy of using ChatGPT, a conversational language model with basic clinical knowledge, in alleviating decision conflict for patients with new diagnosis in otolaryngology. For this pilot study, vestibular schwannoma, a benign tumor that develops on the vestibular nerve with known clinical equipoise, has been chosen for the initial study diagnosis. Efficacy will be evaluated by comparison of responses to the Decisional Conflict Scale (DCS) and Satisfaction with Decision (SWD) scores between a group given training in ChatGPT and a control group (no ChatGPT training).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: November 30, 2025
• Est. primary completion date: June 30, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years or older

• Diagnosed with vestibular schwannoma

• Have access to internet-enabled device that is compatible with ChatGPT

Exclusion Criteria:

• < 18 years old

• patient without diagnosis of vestibular schwannoma

• patient does not have access to internet-enabled device

• patient who declines study participation

Related Conditions & MeSH terms

• Neurilemmoma
• Neuroma, Acoustic
• Vestibular Schwannoma

Intervention

Behavioral:
• Use of chatGPT for 1 week
Use of chatGPT for 1 week

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Southern California

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in scores of Decisional Conflict Scale after ChatGPT use	The Decisional Conflict Scale (DCS) measures 5 dimensions of decision making (feeling: uncertain, uninformed, unclear about values, unsupported; ineffective decision making). 15-item validated questionnaire. Score range 5-75 (higher score corresponding to higher levels of conflict in decision making)	baseline, 1 week follow up, 2 week follow up
Primary	Changes in scores of Satisfaction with Decision after ChatGPT use	The Satisfaction with Decision (SWD) scale measures satisfaction with health care decisions. 6-item validated questionnaire. Score range 5-30 (higher score corresponding to higher levels of satisfaction with decision)	baseline, 1 week follow up, 2 week follow up
Primary	Changes in scores for Knowledge on vestibular schwannoma management after ChatGPT use	4-item questionnaire (Likert scale) assessing participants' confidence in understanding the diagnosis and treatment options for vestibular schwannoma. Score range 5-20 (higher score corresponding to higher levels of confidence in understanding diagnosis and management of vestibular schwannoma)	baseline, 1 week follow up, 2 week follow up